With the approval of the first OTC oral contraceptive, pharmacists play an ever-increasing role in helping expand access to reproductive health care. The Conversation — On July 13, 2023, the US Food ...
Lenacapavir does not appear to cause any clinically significant effects in the pharmacokinetics of long-acting hormonal contraceptives or gender-affirming hormone therapy, according to a pair of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback